Jimmy Lin, Author at Future
Jimmy Lin is CSO at Freenome. Previously, he served as CSO for Oncology at Natera and led the intramural clinical genomics program at the National Cancer Institute at the National Institutes of Health.| Future
Jimmy Lin is CSO at Freenome. Previously, he served as CSO for Oncology at Natera and led the intramural clinical genomics program at the National Cancer Institute at the National Institutes of Health.| Future
AI expert Daphne Koller of insitro identifies what we'll need for future AlphaFold-level successes and explains why some fail the academia-to-biotech transition.| Future
The first half of 2022 saw momentum gains for a movement at the intersection of web3 and science: decentralized science (DeSci).| Future
AI-created models of the brain will enhance art, advertising, and health by predicting how our minds will respond to images and sounds.| Future
A GPT-3-like AI model for science would accelerate innovation and improve reproducibility. Creating it will require us to unlock research.| Future
Caltech Professor Magda Zernicka-Goetz explains recent progress in building 'synthetic' embryos from stem cells and their applications.| Future
